Search Results - "Crabb, Nick"
-
1
The Health Technology Assessment of companion diagnostics: experience of NICE
Published in Clinical cancer research (15-03-2014)“…Companion diagnostics are used to aid clinical decision making to identify patients who are most likely to respond to treatment. They are becoming increasingly…”
Get full text
Journal Article -
2
Outcome-based reimbursement in Central-Eastern Europe and Middle-East
Published in Frontiers in medicine (23-09-2022)“…Outcome-based reimbursement models can effectively reduce the financial risk to health care payers in cases when there is important uncertainty or…”
Get full text
Journal Article -
3
New ways of evaluating and purchasing antimicrobials
Published in The Lancet infectious diseases (01-11-2022)“…The maximum annual payment of £10 million reflects an appropriate incentive if other countries pay proportionately similar amounts; the actual payment is…”
Get full text
Journal Article -
4
Use of Patient Preference Studies in HTA Decision Making: A NICE Perspective
Published in The patient : patient-centered outcomes research (01-04-2020)“…Patient preference studies could provide valuable insights to a National Institute for Health and Care Excellence committee into the preferences patients have…”
Get full text
Journal Article -
5
Environmental impact assessment in health technology assessment: principles, approaches, and challenges
Published in International journal of technology assessment in health care (23-02-2023)“…To reduce harm to the environment resulting from the production, use, and disposal of health technologies, there are different options for how health…”
Get more information
Journal Article -
6
Can the UK ‘Netflix’ Payment Model Boost the Antibacterial Pipeline?
Published in Applied health economics and health policy (01-05-2023)“…The silent pandemic of antimicrobial resistance (AMR) is a global issue needing prompt attention. A comprehensive one-health approach across human and animal…”
Get full text
Journal Article -
7
How should we assess the clinical and cost effectiveness of histology independent cancer drugs?
Published in BMJ (Online) (02-01-2020)“…Sophie Cooper, Jacoline Bouvy and colleagues discuss the challenges that histology independent cancer drugs will pose for NICE and the NHS…”
Get full text
Journal Article -
8
Recognizing that Evidence is Made, not Born
Published in Clinical pharmacology and therapeutics (01-04-2019)“…Therapeutic product development, licensing and reimbursement may seem a well‐oiled machine, but continuing high attrition rates, regulatory refusals, and…”
Get full text
Journal Article -
9
The Health Technology Assessment of Companion Diagnostics: Experience of NICE : PRECISION MEDICINE
Published in Clinical cancer research (2014)Get full text
Journal Article -
10
How should we assess the clinical and cost effectiveness of histology independent cancer drugs?
Published in BMJ (Online) (05-01-2020)Get full text
Journal Article -
11
The NICE Diagnostics Assessment Programme
Published in Health policy and technology (01-03-2012)“…The Diagnostics Assessment Programme (DAP) was set up by NICE in 2009 to evaluate innovative medical diagnostic technologies. It was established together with…”
Get full text
Journal Article -
12
NICE supports allowing technology assessment bodies to provide advice to drug industry
Published in BMJ (Online) (13-08-2014)Get full text
Journal Article